Figure 2.

Patient’s health-related quality of life: visual analog scale (VAS) score during abiraterone treatment.

Data for VAS were available from 431 patients at baseline, 329 at 6-month follow-up, 224 at 12-month follow-up, 139 at 18-month follow-up and 68 at 24-month follow-up. The signed rank test was used to test changes from baseline. p-values were 0.001 for changes at 6 months, 0.159 for changes at 12 months, 0.526 for changes at 18 months, and 0.753 for changes at 24 months of follow-up.